• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient.一名自体干细胞移植受者发生肝窦阻塞综合征及白消安诱导的肺损伤
Indian Pediatr. 2017 Sep 15;54(9):765-770. doi: 10.1007/s13312-017-1172-5.
2
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.白消安、美法仑和噻替派预处理治疗后发生的肝静脉闭塞性疾病:发病率、危险因素及预后
Biol Blood Marrow Transplant. 1999;5(5):306-15. doi: 10.1016/s1083-8791(99)70006-6.
3
Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.在接受白消安预处理的异基因造血细胞移植后,一名HFE H63D纯合子患者出现类似肝静脉闭塞病的亚急性肝坏死。
Int J Hematol. 2015 Dec;102(6):729-31. doi: 10.1007/s12185-015-1878-x.
4
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.BCSH/BSBMT 指南:造血干细胞移植后静脉闭塞病(窦状隙阻塞综合征)的诊断和治疗。
Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.
5
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.吉尔伯特综合征患者接受含白消安预处理治疗及造血细胞移植后的死亡率结局:一项回顾性队列研究
Lancet Haematol. 2016 Nov;3(11):e516-e525. doi: 10.1016/S2352-3026(16)30149-1.
6
Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation.清髓性化疗和自体移植后的特发性肺炎综合征
Ann Pharmacother. 2001 Feb;35(2):196-201. doi: 10.1345/aph.10071.
7
Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children.幼儿造血干细胞移植后输注含ABO血型不相合血浆的血小板与肝静脉闭塞病
Transplantation. 2005 Aug 15;80(3):314-9. doi: 10.1097/01.tp.0000167758.63247.f4.
8
Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.左乙拉西坦用于预防小儿造血干细胞移植受者中白消安诱导的癫痫发作。
J Oncol Pharm Pract. 2017 Jul;23(5):344-349. doi: 10.1177/1078155216651128. Epub 2016 May 20.
9
I-Meta-iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high-risk neuroblastoma.高危神经母细胞瘤中碘[131I]-间位碘苄胍、马法兰和白消安治疗加自体干细胞解救。
Pediatr Blood Cancer. 2021 Feb;68(2):e28775. doi: 10.1002/pbc.28775. Epub 2020 Oct 24.
10
Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients.评价白消安和 DMA 对儿科干细胞受者 SOS 的影响。
Pediatr Blood Cancer. 2014 Feb;61(2):306-11. doi: 10.1002/pbc.24827. Epub 2013 Oct 30.

引用本文的文献

1
Busulfan Chemotherapy Downregulates TAF7/TNF-α Signaling in Male Germ Cell Dysfunction.白消安化疗可下调男性生殖细胞功能障碍中的TAF7/TNF-α信号通路。
Biomedicines. 2024 Sep 28;12(10):2220. doi: 10.3390/biomedicines12102220.
2
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.高危神经母细胞瘤患儿中白消安所致肺损伤的管理
J Clin Med. 2024 Oct 8;13(19):5995. doi: 10.3390/jcm13195995.

本文引用的文献

1
Sinusoidal obstruction syndrome.窦状隙阻塞综合征。
Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):378-85. doi: 10.1016/j.clinre.2016.01.006. Epub 2016 Mar 30.
2
Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).窦性阻塞综合征(肝静脉闭塞病)
J Clin Exp Hepatol. 2014 Dec;4(4):332-46. doi: 10.1016/j.jceh.2014.10.002. Epub 2014 Oct 30.
3
Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.血清半乳甘露聚糖检测在血液恶性肿瘤患儿侵袭性曲霉菌病诊断中的应用。
Mycoses. 2013 Jul;56(4):442-8. doi: 10.1111/myc.12048. Epub 2013 Feb 1.
4
Prediction of veno-occlusive disease using biomarkers of endothelial injury.使用内皮损伤生物标志物预测静脉闭塞性疾病。
Biol Blood Marrow Transplant. 2010 Aug;16(8):1180-5. doi: 10.1016/j.bbmt.2010.02.016. Epub 2010 Feb 23.
5
Vascular disorders of the liver.肝脏血管疾病
Hepatology. 2009 May;49(5):1729-64. doi: 10.1002/hep.22772.
6
Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide.使用白消安和环磷酰胺预处理的异基因骨髓移植5年后的肺功能。
Eur Respir J. 2004 Jun;23(6):901-5. doi: 10.1183/09031936.04.00084804.
7
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.造血干细胞移植后肝静脉闭塞病(窦性阻塞综合征)
Mayo Clin Proc. 2003 May;78(5):589-98. doi: 10.4065/78.5.589.
8
The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.纤溶酶原激活物抑制剂1(PAI-1)作为骨髓移植后患者肝静脉闭塞病诊断标志物的相关性。
Leuk Lymphoma. 1999 Mar;33(1-2):25-32. doi: 10.3109/10428199909093722.
9
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.血液或骨髓移植后肝静脉闭塞病的发病率及转归:欧洲血液和骨髓移植组的一项前瞻性队列研究。欧洲血液和骨髓移植组慢性白血病工作组
Blood. 1998 Nov 15;92(10):3599-604.
10
Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications.
Ann Hematol. 1998 Feb;76(2):61-5. doi: 10.1007/s002770050364.

一名自体干细胞移植受者发生肝窦阻塞综合征及白消安诱导的肺损伤

Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient.

作者信息

Jain Richa, Gupta Kirti, Bhatia Anmol, Bansal Arun, Bansal Deepak

机构信息

Departments of Pediatrics (Hematology-Oncology Division), *Histopathology and Radiodiagnosis; PGIMER, Chandigarh, India. Correspondence to: Dr Kirti Gupta, Professor, Department of Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. India.

出版信息

Indian Pediatr. 2017 Sep 15;54(9):765-770. doi: 10.1007/s13312-017-1172-5.

DOI:10.1007/s13312-017-1172-5
PMID:28984258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7097441/
Abstract

Veno-occlusive disease of the liver is mostly encountered as a complication of hematopoietic stem cell transplantation with myeloablative regimens with an incidence estimated to be 13.7%. It is clinically characterized by tender hepatomegaly, jaundice, weight gain and ascites. Strong clinical suspicion and an early recognition of clinical signs are essential to establish the diagnosis and institute effective regimen. Another complication of cytotoxic drugs given for cancers, is development of busulfan-induced lung injury. A strong index of suspicion is needed for its diagnosis, especially in setting where opportunistic fungal and viral infections manifest similarly. We illustrate the clinical and autopsy finings in a 2½-year-old boy who received autologous stem-cell transplantation following resection of stage IV neuroblastoma. He subsequently developed both hepatic veno-occlusive disease and busulfan-induced lung injury. The autopsy findings are remarkable for their rarity.

摘要

肝静脉闭塞病大多是清髓性造血干细胞移植的并发症,采用清髓方案时估计发病率为13.7%。其临床特征为肝肿大伴压痛、黄疸、体重增加和腹水。强烈的临床怀疑和对临床体征的早期识别对于确立诊断和制定有效的治疗方案至关重要。用于癌症治疗的细胞毒性药物的另一个并发症是白消安诱导的肺损伤。其诊断需要高度怀疑指数,尤其是在机会性真菌和病毒感染表现相似的情况下。我们展示了一名2岁半男孩的临床和尸检结果,该男孩在IV期神经母细胞瘤切除术后接受了自体干细胞移植。他随后发生了肝静脉闭塞病和白消安诱导的肺损伤。尸检结果因其罕见性而引人注目。